The impact of vitamin A deficiency on reproductive health, in terms of its repercussions on maternal and infant health, has been well-documented (1-5). Identification of women at risk of vitamin A deficiency during pregnancy allows for intervention, aimed at improving maternal hepatic vitamin A reserves and preventing insufficient placental transfer to the foetus, as observed in cases of severe maternal deficiency (6,7). The measures currently recommended for the prevention and treatment of gestational vitamin A deficiency and nightblindness are based on supplementation, food enrichment with vitamin A, and alimentary diversification (4,8,9), always considering the ingestion amount safe for each biological moment (10).
To meet the expectations of international health committees and the scientific community, several less-invasive, low-cost indicators have been tested and validated for diagnosing vitamin Adeficiency, which is still a public-health problem in various parts of the world (4,5,8).
Evaluation of nightblindness through a standardized interview has been widely employed by researchers in population-based studies, through a low-cost, simple, culturally-accepted methodology, allowing for the detection of high rates of prevalence of maternal and infant vitamin A deficiency (1-3,11,12).
During the 1930s, Ricketts reported two cases of pregnant women with vitamin A deficiency in the USA, presenting nightblindness associated with vomiting, headache, and anaemia (13). In the 1960s, Dixit reported 38.9% of pregnant women with nightblindness in India, principally in the third trimester, with remission of ocular symptoms during the postpartum period (14). In both the studies, supplementation of vitamin A during pregnancy was followed by remission of symptoms and nightblindness.
Gestational nightblindness was formerly attributed to physiological adjustments in pregnancy (14), but recent studies conducted in Asia have described the association between this ocular symptom and a fivefold risk of maternal mortality during two years postpartum compared to women without gestational nightblindness (2). Increased mortality among infants during the first six months of life also appears to be associated with gestational nightblindness (3). In addition, pregnant women with nightblindness and vitamin Adeficiency appear to be more predisposed to complications during pregnancy, such as spontaneous abortion, urinary, genital and gastrointestinal infections, pregnancy-induced hypertension, other digestive signs and symptoms, and decreased appetite (1,15,16). Hence, gestational nightblindness was recently suggested as a marker for high-risk gestations (17).
The International Vitamin A Consultative Group (IVACG) recommended that the rates of maternal nightblindness should be routinely investigated in nutrition and health surveys, given the associated risk for health and nutritional status (4,18). The IVACG also recommends evaluation of gestational nightblindness in regions, such as Africa and Latin America (18).
Thus, the aim of the present study was to describe the prevalence of gestational nightblindness among postpartum women and to evaluate the association of ocular symptom with a biochemical indicator (serum retinol levels) and with obstetric history, antenatal care, sociodemographic and anthropometric variables.
MATERIALS AND METHODS
The study population comprised postpartum women who had received prenatal care at the University Maternity Hospital of the Federal University in Rio de Janeiro, Brazil. This healthcare facility provides free childbirth care to 1,400-1,500 patients per year from various areas in the city, with characteristics similar to those women treated at other public maternity hospitals in the city of Rio de Janeiro, Rio de Janeiro State, in the southeast region of Brazil.
During 1999-2001, 262 participants were selected for the study on alternative days in four weekly shifts. …